Abstract
Low expression of the CD3zeta chain has been reported in patients with cancer and it has been suggested that tumor-derived factors are involved in its downregulation. The expression of CD3zeta chain was measured in T-cell lines from patients with gastric adenocarcinoma and healthy volunteers and grown in vitro for several months and, hence, in the absence of any tumor-derived factors. T-cell lines of mucosal origin were obtained by Herpesvirus saimiri transformation from gastric cancer patients. The expression of CD3zeta and CD3epsilon was measured by flow cytometry and Western-blot analysis. Calcium mobilization and apoptosis rate were also measured. The levels of CD3zeta, but not CD3epsilon, chain on the cell surface were significantly reduced in T-cell lines derived from patients with gastric cancer when cultured in the absence of IL-2. Western-blot analysis of total cell extracts or lipid raft fractions confirmed this finding. Calcium mobilization, a measure of signal transduction, was reduced in T cell lines from patients with gastric cancer. We conclude that T cells from patients with cancer express lower levels of CD3zeta. This downregulation is not caused by a direct effect of tumor-derived factors but, rather, it appea...Continue Reading
References
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·B BiesingerB Fleckenstein
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A BauerE L Reinherz
Jun 1, 1996·European Journal of Immunology·K KonoR Kiessling
Jul 22, 1998·Journal of Immunotherapy·T E ReichertT L Whiteside
Dec 24, 1998·Tissue Antigens·J M Martin-VillaA Arnaiz-Villena
Jan 8, 1999·Cellular Immunology·C B LopezA B Frey
Jul 8, 1999·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·C W KimY J Bang
Apr 20, 2000·The Journal of Biological Chemistry·D A Brown, E London
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·A LetschC Scheibenbogen
Nov 1, 2000·Cell·M L Dustin, A C Chan
Jun 8, 2001·Surgery·D C LockhartT J Eberlein
Jul 10, 2002·Trends in Immunology·Daniel M Davis
Jun 28, 2003·Cancer Immunology, Immunotherapy : CII·A P ValeriJ M Martín-Villa
Jun 9, 2004·Cancer Immunology, Immunotherapy : CII·G Pawelec
Sep 3, 2004·Nature Reviews. Immunology·Michal Baniyash
Citations
Sep 19, 2009·Expert Review of Anticancer Therapy·Ana Paula de Souza, Cristina Bonorino
Oct 5, 2010·Cell Biology International·Bin Yu, Wei Zhang
Dec 1, 2006·Molecular Immunology·Mercedes Lopez-SantallaJosé M Martin-Villa